Elsevier Ltd.
+2
2352-9148
Quarterly
2015
442074832293
United Kingdom
English
YES
Google Scholar
journalscustomerserviceEMEA@elsevier.com
Informatics in Medicine Unlocked (IMU) is an international gold open access journal covering a broad spectrum of topics within medical informatics, including (but not limited to) papers focusing on imaging, pathology, teledermatology, public health, ophthalmological, nursing and translational medicine informatics. The full papers that are published in the journal are accessible to all who visit the website. Manuscripts exploring the revolutionary advances being made in the application of the computer to the fields of bioscience and medicine can be submitted to the journal?s companion title, Computers in Biology and Medicine . Only manuscripts of sufficient quality with scientific relevance will be considered for publication in IMU; the types of articles accepted include original research papers, reviews, perspectives, letters to the editor and editorials, tutorials, and papers on innovative and topical new technology. Proposals for special focus issues from leading research groups will also be considered. Manuscript referees will be experts in the subject matter, working in academia, industry, and at government institutions. Usually, comments from 2-5 referees will be returned to the authors after first submission of the manuscript. Average turnaround time for manuscript evaluation is expected to be less than 4 weeks. Average time from first submission to publication of accepted papers, including revision, will typically be 2-4 months.
Coronavirus disease 2019 (COVID-19)-driven global pandemic triggered innumerable health complications, imposing great challenges in managing other respiratory diseases like asthma. Furthermo...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been circulating since 2019, and its global dominance is rising. Evidences suggest the respiratory illness SARS-CoV-2 has a s...
The prolonged use, incorrect diagnosis, unnecessary prescription, improper dosing over the year has transformed klebsiella organisms into resistant to antibiotics. The emergence of resistanc...
Alzheimer's disease and Huntington's disease are considered to be the most lethal illnesses that result in common human disorders. Alzheimer's disease (AD) is a progressive neurological illn...
Progression in computational research has made it possible for the in silico methods to offer epochal benefits to both regulatory needs and the pharmaceutical industry to assess the safety p...
Bipolar disorder (BD), also referred to as manic depression, is a mental illness marked by significant mood fluctuations as well as changes in sleep, energy, thinking, and behavior. About 1%...
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection results in the development of a highly contagious respiratory ailment known as new coronavirus disease (COVID-19). Desp...
OJSCloud offers a complete, free setup to get you publishing.
Start Your Free Journal!Scholar9.com is a peer-review platform that hosts journals from across the globe. Please note that we do not own any of the journals hosted on the platform.
Our platform enables journal owners to send articles for peer review to users who have registered via https://scholar9.com/register and have consented to serve as reviewers for multiple journals. Additionally, we offer an indirect manuscript submission system for journals that are claimed and actively managed by their respective owners on Scholar9.com.
For accurate information about the indexing status of journals (in databases such as UGC CARE, Scopus, or Web of Science) and contact details, users must refer to the respective official websites.
Scholar9 is not responsible for indexing claims, manuscript acceptance/rejection, refunds of article processing charges, or any stage of the final publication process. Users are strongly advised to verify all information provided on the platform independently.
Scholar9.com disclaims liability for disputes related to indexing claims, publication decisions, or other journal-specific matters. Users are encouraged to contact the respective journal owners directly for detailed information and clarifications.